New International Council on Biotechnology Associations advocates biotechnology growth.
The Biotechnology Industry Organization (BIO) is reporting that an international confederation of biotechnology trade associations has created the International Council on Biotechnology Associations (ICBA) to advocate for public policies that support worldwide biotechnology growth. BIO’s president and CEO, Jim Greenwood, has been elected to serve as ICBA Chairman, and Nathalie Moll, secretary general of EuropaBio, was elected Vice Chair.
“The increasingly global biotechnology industry provides breakthrough products and technologies that combat debilitating and rare diseases, reduce our environmental footprint, feed the hungry, use less and cleaner energy, and have safer, cleaner and more efficient industrial manufacturing processes,” said Greenwood in a press release. “However, the biotechnology sector faces both challenges and opportunities that cross borders. In forming the ICBA, our industry is taking an important step that allows us to better coordinate, organize and face these issues around the world together."
“Biotechnology is geared at enhancing our quality of life and responding to society’s grand challenges such as an ageing and ever increasing population, healthcare choice and affordability, resource efficiency, food security, climate change, energy shortages and economic growth,” said Moll in the press release. “The ICBA will advocate for more efficient and effective governance, science-based regulatory systems and the right framework conditions for competitiveness and innovation to ensure faster and more equitable access to biotech products and processes for patients, farmers and consumers around the world.”
Source:
BIO.org
Drug Solutions Podcast: A Closer Look at mRNA in Oncology and Vaccines
April 30th 2024In this episode fo the Drug Solutions Podcast, etherna’s vice-president of Technology and Innovation, Stefaan De Koker, discusses the merits and challenges of using mRNA as the foundation for therapeutics in oncology as well as for vaccines.
Drug Solutions Podcast: Applying Appropriate Analytics to Drug Development
March 26th 2024In this episode of the Drug Solutions Podcast, Jan Bekker, Vice President of Business Development, Commercial and Technical Operations at BioCina, discusses the latest analytical tools and their applications in the drug development market.
Pharmaceutical Tariffs Are Imminent: How Industry is Bracing for Impact
April 16th 2025On April 14, 2025, the Trump Administration launched a national security-driven investigation into pharmaceuticals, a move that will likely result in tariffs being placed on pharmaceutical drugs, ingredients, and other components that are imported from outside of the United States.